老虎證券

BRIEF-Lilly's Ebglyss Single Monthly Maintenance Injection Achieved Completely Clear Skin At Three Years In Half Of Patients With Moderate-To-Severe Atopic Dermatitis

Reuters
03-07
BRIEF-Lilly's Ebglyss Single Monthly Maintenance Injection Achieved Completely Clear Skin At Three Years In Half Of Patients With Moderate-To-Severe Atopic Dermatitis

March 7 (Reuters) - Eli Lilly and Co LLY.N:

  • LILLY'S EBGLYSS® (LEBRIKIZUMAB-LBKZ) SINGLE MONTHLY MAINTENANCE INJECTION ACHIEVED COMPLETELY CLEAR SKIN AT THREE YEARS IN HALF OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Source text: ID:nPn8RBwpma

Further company coverage: LLY.N

(Reuters.Briefs@thomsonreuters.com)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10